Patent ID: 11918613
Assignee: FERRING B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 9:
10. The composition of claim 1, further comprising one or more bacteriophages selected from:
bacteriophages of strain P1 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4694, or a variant thereof, wherein the variant has the same lytic activity and at least 80% sequence identity on at least 70% of length as said deposited bacteriophage strain P1;
bacteriophages of strain P3 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4696, or a variant thereof, wherein the variant has the same lytic activity and at least 80% sequence identity on at least 70% of length as said deposited bacteriophage strain P3;
bacteriophages of strain P4 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4697, or a variant thereof, wherein the variant has the same lytic activity and at least 80% sequence identity on at least 70% of length as said deposited bacteriophage strain P4;
bacteriophages of strain P5 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4698, or a variant thereof, wherein the variant has the same lytic activity as and at least 80% sequence identity on at least 70% of length said deposited bacteriophage strain P5; and
bacteriophages of strain P6 deposited with the French National Collection of Microorganisms at the Institut Pasteur under Accession Number CNCM 1-4699, or a variant thereof, wherein the variant has the same lytic activity and at least 80% sequence identity on at least 70% of length as said deposited bacteriophage strain P6.